• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/26/2021
Event Type  Injury  
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(4), including the nitinol stent component, as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.Since the device was not returned from the hospital, no further investigation is possible at this time.Based on the available information, it is not possible to draw a definitive conclusion to the reported event, however, from the document review performed, no manufacturing deficiencies were identified.Based on the manufacturer's experience, factors that may contribute to an intraoperative migration of the perceval valve can include manipulation of the heart and/or of the ascending aorta, a not correct positioning of the valve or a device mis-sizing.Given that the same size of the perceval valve was ultimately implanted, mis-sizing can be reasonably excluded.Ultimately, since the involved device is not available for return and no further information has been provided, a definitive root cause cannot be established at this time.The manufacturer is following up with the hospital to retrieve additional information, but no further details on the event have been provided to date.Should further information be received in the future, the manufacturer will provide a follow up report.
 
Event Description
On (b)(6) 2021, the perceval valve pvs23 was used for aortic valve replacement with concomitant procedures - mitral valvuloplasty, tricuspid annuloplasty and left atrial appendage closure.When the positioning of the perceval valve was checked visually, it was observed that the device dropped into the left ventricle side.The device was removed, then another perceval valve pvs23 was implanted, and the operation was completed without any problem.The patient had a good outcome.
 
Manufacturer Narrative
Based on the available information and medical judgment received, the root cause of the reported event was attributed to a mistake in the surgical procedure (use error).However, this aspect was not further specified.From the document review performed, no manufacturing deficiencies were identified.No adverse complications as a result of this event were reported for this patient, who had a good outcome.
 
Event Description
On (b)(6) 2021, the perceval valve pvs23 was used for aortic valve replacement with concomitant procedures (in order): mitral valvuloplasty, tricuspid annuloplasty and left atrial appendage closure.Then, the aortic valve replacement was performed.When the positioning of the perceval valve was checked visually, it was observed that the device dropped into the left ventricle side.The problem was detected immediately after the valve deployment, before the ballooning with the post-dilatation catheter.The device was removed, then another perceval valve pvs23 was implanted, and the operation was completed without any problem.The patient had a good outcome.Based on the medical judgment received, the possible root cause of the reported event was attributed to a mistake in the surgical procedure.It was reported that no further decalcification was performed before the implant of the second perceval valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key13077108
MDR Text Key282719638
Report Number3004478276-2021-00292
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)240811
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/26/2021
Initial Date FDA Received12/23/2021
Supplement Dates Manufacturer Received02/09/2022
Supplement Dates FDA Received02/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-